@JYazdanyMD in the #ACR25 Great AI Debate details out three key risks of AI in rheumatology: - bias at scale - erosion of skills - data regulatory issues (for what it’s worth, amongst all the potential upside, I think it’s very real. It’s up to us to make it better) @RheumNow https://t.co/FyNes40Z7q